Thiazole-2-carboximidamide

Catalog No.: 
ACGBSY382
CAS No.: 
212558-27-5
Molecular Formula: 
C4H5N3S
Molecular Weight: 
127.17
Thiazole-2-carboximidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$124.00InquiryInquiry
100g98%$323.00InquiryInquiry
500g98%$1215.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameThiazole-2-carboximidamide
IUPAC Namethiazole-2-carboximidamide
MDL No.MFCD13184148
Molecular FormulaC4H5N3S
Molecular Weight127.17
SMILESN=C(C1=NC=CS1)N
InChI KeyLKSRVNUPZNSFTE-UHFFFAOYSA-N
Synonym2-Thiazolecarboximidamide;1,3-thiazole-2-carboxiMidaMide;Thiazole-2-carboxiMidaMide;EOS-60666;Thiazole-2-carboxamidine
CAS No.212558-27-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGBSY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMIC273 route compound structure diagram
    ACLMIC2731452-16-0In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACGBSY382 route product structure diagram
    ACGBSY382212558-27-5
Inquiry

2. ACGBSY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACLMIC273 route compound structure diagram
    ACLMIC2731452-16-0In Stock
  4. Then
  5. ACGBSY382 route product structure diagram
    ACGBSY382212558-27-5
Inquiry

3. ACGBSY382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBMC351 route compound structure diagram
    ACDBMC3512386829-95-2In Stock
  2. Then
  3. ACGBSY382 route product structure diagram
    ACGBSY382212558-27-5
Inquiry

Comments (0)